| Stephanie Lynn Sondermann-luther, LPN, CLC | |
|
4712 New Centre Dr Ste 106, Wilmington, NC 28405-3504 | |
| (910) 769-6443 | |
| Not Available |
| Full Name | Stephanie Lynn Sondermann-luther |
|---|---|
| Gender | Female |
| Speciality | Lactation Consultant, Non-rn |
| Location | 4712 New Centre Dr Ste 106, Wilmington, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184958001 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Lynn Sondermann-luther, LPN, CLC 6028 Chancellorsville Dr, Wilmington, NC 28409-0009 Ph: (910) 833-2143 | Stephanie Lynn Sondermann-luther, LPN, CLC 4712 New Centre Dr Ste 106, Wilmington, NC 28405-3504 Ph: (910) 769-6443 |
News Archive
Europe-wide data suggest that mortality rates after noncardiac surgery are higher than expected, and vary substantially by country, reports an international research team in The Lancet.
A team of surgeons at Mount Sinai Beth Israel, led by William B. Inabnet III, MD, the Eugene W. Friedman, MD, Professor of Surgery and Chair for the Department of Surgery at MSBI and Chief of Endocrine Surgery Quality for the Mount Sinai Health System, have performed the first endoscopic transoral thyroidectomy in New York, and one of the first of its kind in the nation.
Science is playing an increasingly prominent role in many controversial political, religious and socio-economic debates, such as those about embryonic stem cells, genetically modified foods, teaching evolution and climate change.
Quality healthcare transcends the medical profession, as evidenced by a new project led by West Virginia University that includes not only health experts but engineers, a physicist, a lawyer and a business data analyst.
Scientists at Texas Biomedical Research Institute (Texas Biomed) today announced the launch of a comprehensive research initiative to investigate multiple animal species and their response to the novel coronavirus disease (COVID-19).
› Verified 4 days ago